Current definitions of phases of investigation and the role of the FDA in the conduct of clinical trials

Am Heart J. 2000 Apr;139(4):S133-5. doi: 10.1016/s0002-8703(00)90060-7.
No abstract available

MeSH terms

  • Cardiovascular Agents*
  • Clinical Trials, Phase I as Topic*
  • Clinical Trials, Phase II as Topic*
  • Clinical Trials, Phase III as Topic*
  • Humans
  • United States
  • United States Food and Drug Administration*

Substances

  • Cardiovascular Agents